|
C11ORF58 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.042200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.114600E-01 |
| Normal-vs-Stage2 |
8.177000E-01 |
| Normal-vs-Stage3 |
1.575150E-03 |
| Normal-vs-Stage4 |
1.643970E-04 |
| Stage1-vs-Stage2 |
9.381600E-01 |
| Stage1-vs-Stage3 |
3.256000E-03 |
| Stage1-vs-Stage4 |
4.209200E-04 |
| Stage2-vs-Stage3 |
6.671700E-02 |
| Stage2-vs-Stage4 |
5.142500E-02 |
| Stage3-vs-Stage4 |
7.560000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.534300E-02 |
| Normal-vs-AfricanAmerican |
6.410400E-04 |
| Normal-vs-Asian |
4.068600E-01 |
| Caucasian-vs-AfricanAmerican |
2.874000E-02 |
| Caucasian-vs-Asian |
9.482200E-01 |
| AfricanAmerican-vs-Asian |
4.435400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.996400E-02 |
| Normal-vs-Female |
5.106100E-02 |
| Male-vs-Female |
9.675200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.807400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.592150E-01 |
| Normal-vs-Age(61-80Yrs) |
9.837500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.831380E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.628200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.476800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.188600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.643600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.010800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.254800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.095200E-01 |
| Normal-vs-Grade 2 |
8.263600E-01 |
| Normal-vs-Grade 3 |
4.433200E-04 |
| Normal-vs-Grade 4 |
2.36279999999978E-05 |
| Grade 1-vs-Grade 2 |
2.568000E-01 |
| Grade 1-vs-Grade 3 |
5.042300E-03 |
| Grade 1-vs-Grade 4 |
2.699800E-03 |
| Grade 2-vs-Grade 3 |
8.0677000000029E-05 |
| Grade 2-vs-Grade 4 |
1.83301999999719E-05 |
| Grade 3-vs-Grade 4 |
8.081800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.594400E-01 |
| Normal-vs-ccB subtype |
5.026800E-04 |
| ccA subtype-vs-ccB subtype |
2.49200000002059E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.741700E-02 |
| Normal-vs-N1 |
1.244350E-03 |
| N0-vs-N1 |
1.491190E-01 |
|
|
